GIP Contains Tirzepatide
  • Weight Loss
  • In Stock

Weekly Dual Power

Personalized Tirzepatide (GLP-1/GIP) Injection

Double the targets. Maximize your results.

  • The Dual Advantage: A next-generation agonist that targets two hunger hormones (GLP-1 + GIP) instead of one.

  • How It Works: Works double-duty to quiet food noise and improve how your body processes sugar.

  • The Result: Clinically shown to offer superior weight loss potential compared to single-hormone treatments.

  • The Routine: A simple, convenient weekly injection.

Annually Quarterly Monthly
$239 $259 $269

Paid in full, shipped monthly with subscription plans.

Get Started
×

Dosing, Pricing, Shipping

  • Clinician-Led Dosing: Your provider prescribes your exact dose based on your goals.

  • Flat-Rate Pricing: The price is the same for every dose. Save more with annual plans.

  • Monthly Refresh: Ships every 30 days to guarantee freshness and allow for dose adjustments.

Potential Benefits

Prescription appetite suppression:
GLP-1/GIP leverages dual-action technology to target two distinct hunger hormones (GLP-1 and GIP) simultaneously. This "double-defense" approach offers enhanced control over appetite and cravings compared to single-hormone treatments.

Scientifically backed weight loss aid:
GLP-1/GIP represents the next generation of weight management, with clinical trials demonstrating superior efficacy where patients achieved up to 20% body weight loss, surpassing results seen in traditional GLP-1 therapies.

Metabolic health booster:
GLP-1/GIP optimizes metabolic function by regulating blood sugar and insulin sensitivity more aggressively than single agonists. This helps further decrease the risk of obesity-related conditions such as type 2 diabetes, high blood pressure, and cardiovascular disease.

Enhanced quality of life:
GLP-1/GIP accelerates the journey to a healthy weight, helping to rapidly alleviate symptoms like fatigue and joint pain. Patients often report significantly improved mobility and sustained energy levels throughout the day.

Order Fulfillment

A licensed provider will review your medical intake within 48 hours. You will then be prompted to schedule a visit with the provider.

Processing can take 2 – 10 business days (subject to pharmacy partners).

Once ready, shipping is via 2-day.

Disclaimer

This product is prescribed by a licensed healthcare provider based on the individual needs. These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved, and their safety and efficacy have not been independently verified by the FDA. This information is provided for educational purposes only and should not be considered medical advice.

Frequently Asked Questions

Tirzepatide is a breakthrough "dual-agonist" medication that mimics two natural hormones in your body: GLP-1 and GIP. While GLP-1 works to curb appetite, the addition of GIP helps improve how your body breaks down sugar and fat. This double-action approach helps you feel full sooner, maximizes calorie burning, and supports healthy blood sugar levels.
The main difference is the "dual-action" formula. Semaglutide targets one hormone (GLP-1), while Tirzepatide targets two (GLP-1 and GIP). Clinical trials suggest this combination can lead to greater weight loss (up to 20% of body weight) and may offer a more comfortable experience for those with sensitive stomachs.
Yes, it is considered safe and effective when prescribed by a clinician. Common side effects are mild and transient, including nausea, diarrhea, or constipation as your body adjusts. Interestingly, because the GIP hormone can have a calming effect on the stomach, some patients report fewer side effects with Tirzepatide than with single-hormone treatments.
We do not use a "one-size-fits-all" dosing chart. Your provider will prescribe a specific dose based on your medical intake and goals. We ship a fresh supply every 30 days, which allows us to adjust your dosage monthly—titrating you up or down as needed to maximize results while minimizing side effects.
Tirzepatide is not recommended for patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also not recommended if you are pregnant, breastfeeding, or have a history of pancreatitis.
Tirzepatide is a subcutaneous injection, meaning it goes into the fatty layer just under your skin (not a vein/muscle). It is administered once weekly, preferably on the same day each week. Common injection sites include the abdomen or thigh. For step-by-step video instructions, please view our Injection Guide.
Ideally, your medication should be kept refrigerated (between 36°F and 46°F) to maintain maximum potency. However, it is generally stable at room temperature for up to 21 days. If your shipment sat on your porch for a few hours, it is likely still safe to use, but place it in the fridge as soon as possible.
Yes. Transparency is key to safe medical care. We recommend sharing your Vivoro treatment plan with your primary care physician to ensure all your providers are aligned on your health goals.